Accessibility Statement

We are committed to providing a website that is accessible to the widest possible audience. To do so, we are actively working with consultants to update the website by increasing its accessibility and usability by persons who use assistive technologies such as automated tools, keyboard-only navigation, and screen readers.

We are working to have the website conform to the relevant standards of the Section 508 Web Accessibility Standards developed by the United States Access Board, as well as the World Wide Web Consortium's (W3C) Web Content Accessibility Guidelines 2.1. These standards and guidelines explain how to make web content more accessible for people with disabilities. We believe that conformance with these standards and guidelines will help make the website more user friendly for all people.

Our efforts are ongoing. While we strive to have the website adhere to these guidelines and standards, it is not always possible to do so in all areas of the website. If, at any time, you have specific questions or concerns about the accessibility of any particular webpage, please contact WebsiteAccess@tenethealth.com so that we may be of assistance.

Thank you. We hope you enjoy using our website.

Skip to Main Content

Implantable device replaces CPAP for sleep apnea sufferers

Jul 23, 2018

Carondelet St. Mary's Hospital offers Inspire Upper Airway Stimulation therapy

TUCSON (July 23, 2018) – Carondelet St. Mary's Hospital is now offering a new treatment option for obstructive sleep apnea for patients who cannot use Continuous Positive Airway Pressure (CPAP) therapy.

The new treatment - known as Inspire Upper Airway Stimulation (UAS) therapy - offers the first implantable device for treating obstructive sleep apnea. The therapy works from inside the body and with the patient's natural breathing process.

Inspire UAS sleep apnea deviceThe implantable system includes a small generator, a sensing lead and a stimulation lead. Turned on by a handheld remote, it delivers mild stimulation to key airway muscles, which keeps the airway open during sleep.

For many patients, the Inspire system can be implanted during an outpatient procedure.

"In our practice we see many patients who have stopped using or are unable to tolerate CPAP," said AJ Emami, MD. "This new therapy represents a significant advance in sleep apnea treatment. It is clinically proven to reduce sleep apnea events and also has a high level of patient satisfaction and therapy adherence."

Patients may experience some pain and swelling at incision sites but should be able to return to nonstrenuous activities after a few days. Approximately one month after implantation, patients return to their doctor's office where personalized stimulation settings are established and patients are trained to use the handheld sleep remote.

  • More than 18 million Americans have sleep apnea.
  • Obstructive sleep apnea - the most common type - can be a potentially life-threatening condition.
  • Research shows that people with poorly managed sleep apnea are at increased risk for heart attack, stroke, weight gain, high blood pressure and heart failure.
  • While CPAP is often successful, studies show that roughly half of all patients who start CPAP eventually become non-compliant.

In the STAR (Stimulation Therapy for Apnea Reduction) trial, a pivotal clinical trial that tested the safety and efficacy of the new therapy, patients experienced a significant reduction in sleep apnea events and significant improvement in quality of life measures. Results were published in the New England Journal of Medicine.

For more information about this therapy, or to determine if you may be a candidate call 833-276-1963.

Sign Up for Health Tips

Get our advice and upcoming events about weight, pain, heart and more.

Find a Doctor

Need a doctor for your care?